Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trace Lithium Dosage for Prevention of Cognitive Declining in Patients with Mood Illnesses: a Randomized Double Blind Placebo Controlled Trial

NCT06662526 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT06662526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trace Lithium Dosage for Prevention of Cognitive Declining in Patients with Mood Illnesses: a Randomized Double Blind Placebo Controlled Trial
Lead sponsor
University of Chile
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
November 1, 2030
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder (bd), dementia, depression - major depressive disorder, mild cognitive impairment (mci)